Monogram Technologies Receives FDA Response for mBôs TKA System

Company to Conduct Clinical Trial to Produce Additional Information Within 180 DaysAUSTIN, TX / ACCESSWIRE / October 2, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving …
Jetzt den vollständigen Artikel lesen